Scilex Holding Company SCLX Financing Costs And Allocated Expense For Financial Instruments At Fair Value
Financing Costs And Allocated Expense For Financial Instruments At Fair Value at other companies
Other financials
Where this comes from
Reported directly by Scilex Holding Company in its filing.
Tagged under the XBRL concept sclx:FinancingCostsAndAllocatedExpenseForFinancialInstrumentsAtFairValue.
The official record: Scilex Holding Company’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Scilex Holding Company's financing costs and allocated expense for financial instruments at fair value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Scilex Holding Company's financing costs and allocated expense for financial instruments at fair value?
- Scilex Holding Company (SCLX) reported financing costs and allocated expense for financial instruments at fair value of $0 in Q1 2026.
- How has Scilex Holding Company's financing costs and allocated expense for financial instruments at fair value changed year-over-year?
- Scilex Holding Company's financing costs and allocated expense for financial instruments at fair value decreased by 100.0% year-over-year, from $4.06M to $0.
- What does financing costs and allocated expense for financial instruments at fair value mean?
- Aggregates the costs associated with securing financing and the periodic expenses allocated to financial instruments measured at fair value. This metric provides insight into the ongoing cost of capital and the impact of complex financial structures on profitability.